Quantitative detection of Epstein-Barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Cocuzza, Clementina E ^a   Piazza, Fabrizio ^a   Musumeci, Rosario ^a   Oggioni, Davide ^a   Andreoni, Simona ^a   Gardinetti, Margherita ^a   Fusco, Letizia ^a   Frigo, Maura ^b   Banfi, Paola ^c   Rottoli, Maria R ^d   Confalonieri, Paolo ^e   Rezzonico, Monica ^f   Ferrò, Maria T ^g   Cavaletti, Guido ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Clinica Neurologica AO S Gerardo   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

^f Dipartimento di Neurologia AO sant'Anna   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; VIRUS DNA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA EXTRACTION; EBNA 1 GENE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS GENE; VIRUS LOAD; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MONONUCLEAR CELL; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; VIRAL LOAD;

EID: 84899573792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094497     Document Type: Article

References (33)

1. Lassman H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-8. (Pubitemid 46466140)
2. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132: 1175-89.
3. Owens GP, Bennett JL (2012) Trigger, Pathogen, or Bystander: The Complex Nexus Linking Epstein- Barr Virus. Mult Scler 18: 1204-8.
4. Jaquiéry E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, et al (2010) Intrathecal immune response to EBV in early MS. Eur J Immunol 40: 878-87.
5. Lünemann JD, Münz C (2009) EBV in MS: guilty by association? Trends Immunol 30: 243-8.
6. Salvetti M, Giovannoni G, Aloisi F (2009) Epstein-Barr Virus and Multiple Sclerosis. Curr Opin Neurol 22: 201-6.
7. Ascherio A, Munger KL (2010) Epstein-Barr Virus Infection and Multiple Sclerosis: A Review. J Neuroimmune Pharmacol 5: 271-7.
8. Lünemann JD, Kamradt T, Martin R, Munz C (2007) Epstein-Barr virus: enviromental trigger of multiple sclerosis? J Virol 78; 11-12.
9. Lucas RM, Hughes AM, Lay ML, Ponsonby Al, Dwyer DE, et al (2011) Epstein-Barr Virus and Multiple Sclerosis. J Neurol Neurosurg Psychiatry 82: 1142-8.
10. Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, et al (2010) Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 69: 677-93.
11. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, et al (2010) Absence of Epstein-Barr Virus in the Brain and CSF of Patients with Multiple Sclerosis. Neurology 74: 1127-35.
12. Peferoen LA, Lamers F, Lodder LN, Gerritsen WH, Huitinga I, et al (2010) Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133: e137.
13. Tzartos JS, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, et al (2012) Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 78: 15-23.
14. Denne C, Kleines M, Dieckhöfer A, Ritter K, Scheithauer S, et al (2007) Intrathecal Synthesis of Anti-Viral Antibodies in Pediatric Patients. Eur J Paediatr Neurol 11: 29-34. (Pubitemid 46076103)
15. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Domìnguez-Mozo MI, Bartolome M, et al (2008) Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler; 14: 595-601. (Pubitemid 351954400)
16. Mancuso R, Hernis A, Cavarretta R, Caputo D, Calabrese E, et al (2009) Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis. J Med Virol 82: 1051-7.
17. Santiago O, Gutierrez J, Sorlozano A, de Dios Luna J, Villegas E, et al (2010) Relation between Epstein-Barr virus and multiple sclerosis: analytical study of scientific production. Eur J Clin Microbiol Infect Dis; 29: 857-866.
18. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, et al (2009) Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain; 132: 3318-3328.
19. Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM, NeuroproMiSe EBV Working Group (2011) Epstein-Barr Virus in the Multiple Sclerosis Brain: A Controversial Issue-Report. Brain 134: 2772-86.
20. Germi R, Lupo J, Semenova T, Larrat S, Magnat N, et al (2012) Comparison of Commercial Extraction Systems and PCR Assays for Quantification of Epstein-Barr Virus DNA Load in Whole Blood. J Clin Microbiol 50: 1384-1389.
21. Loens K, Bergs K, Ursi D, Goossens H, Ieven M (2007) Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J Clin Microbiol 45: 421-5.
22. Perandin F, Pollara CP, Gargiulo F, Bonfanti C, Manca N (2009) Performance evaluation of the automated NucliSens easy MAG nucleic acid extraction platform in comparison with QIAamp Mini kit from clinical specimens. Diagnostic Microbiology and Infectious Disease 64: 158-65.
23. Dundas N, Leos NK, Mitui M, Revell P, Rogers BB (2008) Comparison of automated nucleic acid extraction methods with manual extraction. J Mol Diagn 10: 311-6. (Pubitemid 352019116)
24. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
25. Yang G, Erdman DE, Kodani M, Kools J, Bowen MD (2011) Comparison of commercial systems for extraction of nucleic acids from DNA/RNA respiratory pathogens. J Virol Methods. 171(1):195-9.
26. Kim S, Park SJ, Namgoong S, Sung H, Kim MN (2009) Comparative evaluation of two automated systems for nucleic acid extraction of BK virus: NucliSens easyMAG versus BioRobot MDx. J Virol Methods. 162(1-2):208-12.
27. Broccolo F, Cocuzza CE (2008). Automated extraction and quantification of oncogenic HPV genotypes from cervical samples by a Real-time PCR-Based System. J Virol Methods 148: 48-57. (Pubitemid 351248983)
28. Aberle SW, Puchhammer-Stöckl E (2002) Diagnosis of herpesvirus infections of the central nervous system. J Clin Virol 25: S79-85. (Pubitemid 34666998)
29. Alvarez R, Cour I, Kanaan A, Benedicto M, Martin-Estefania C, et al (2000) Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR). Enferm infect Microbiol Clin 18: 223-8.
30. Alvarez-Lafuente R, De Las Heras V, Bartolomé M, Garcìa-Montojo M, Arroyo R (2006) Human Herpesvirus 6 and multiple sclerosis: a one-year follow up study. Brain Pathol 16: 20-27.
31. Sotelo J, Ordoñez G, Pineda B (2007) Varicella-zoster virus at relapses of multiple sclerosis. J Neurol 254: 493-500. (Pubitemid 46786726)
32. Lindsey JW, Hatfield LM, Crawford MP, Patel S (2009) Quantitative PCR for Epstein-Barr virus DNA and RNA in Multiple Sclerosis. Mult Scler 15: 153-8.
33. Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, et al (2011) Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 77: 371-379.